Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
4
×
amgen
4
×
biotech
life sciences
national
national blog main
national top stories
new york blog main
astrazeneca
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
allergan
cancer
celgene
clinical trials
duchenne muscular dystrophy
europe blog main
fda
fibrogen
finch therapeutics
What
bio
roundup
fda
monday
opioid
abbvie’s
acquisitions
adults
allergan
approved
august
barbecuing
biggest
biotech
build
busy
buy
camping
cardiologist
center
ceo
check
cholesterol
class
company’s
conference
daniel
day
days
debut
decisions
devices
drug
drugs
dyne’s
flop
gilead
hit
j
j’s
Language
unset
4
×
Current search:
abbvie
×
unset
×
amgen
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
